Entry |
|
Name |
Baxdrostat (USAN/INN) |
Formula |
C22H25N3O2
|
Exact mass |
363.1947
|
Mol weight |
363.4528
|
Structure |
|
Efficacy |
Antihypertensive, Aldosterone synthase inhibitor |
Comment |
Treatment of hypertension associated with inappropriately elevated aldosterone levels
|
Target |
|
Pathway |
hsa04925 | Aldosterone synthesis and secretion |
|
Brite |
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Cytochrome P450
CYP11B2
D12789 Baxdrostat (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 27
1 C8x C 17.6400 -13.7900
2 C8y C 17.6400 -15.1900
3 C8x C 18.8524 -15.8900
4 C8y C 20.0649 -15.1900
5 C8y C 20.0649 -13.7900
6 C8x C 18.8524 -13.0900
7 C1x C 21.2773 -15.8900
8 C1x C 22.4897 -15.1900
9 C5x C 22.4897 -13.7900
10 N1y N 21.2773 -13.0900
11 O5x O 23.6873 -13.0985
12 C1a C 21.2773 -11.6900
13 C8y C 16.4276 -15.8900
14 C8x C 15.2321 -15.1996
15 N5x N 14.0196 -15.8995
16 C8x C 14.0194 -17.2995
17 C8y C 15.2149 -17.9899
18 C8y C 16.4274 -17.2900
19 C1y C 15.2147 -19.3899
20 C1x C 16.4271 -20.0900
21 C1x C 17.6396 -19.3901
22 C1x C 17.6398 -17.9901
23 N1b N 13.9838 -20.1006
24 C5a C 12.7790 -19.4050
25 C1b C 11.5963 -20.0878
26 C1a C 10.4027 -19.3985
27 O5a O 12.7788 -17.9903
BOND 30
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 9 11 2
13 10 12 1
14 2 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 16 17 1
19 17 18 2
20 13 18 1
21 17 19 1
22 19 20 1
23 20 21 1
24 21 22 1
25 18 22 1
26 19 23 1 #Up
27 23 24 1
28 24 25 1
29 25 26 1
30 24 27 2
|